Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway
Mg. Fu et al., Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway, CIRCUL RES, 89(11), 2001, pp. 1058-1064
Vascular diseases such as atherosclerosis are characterized by abnormal acc
umulation of vascular smooth muscle cells (VSMCs) within the intimal lining
. The intimal VSMCs exhibit an increased expression of peroxisome prolifera
tor-activated receptor gamma (PPAR gamma), and the administration of pharma
cological PPAR gamma agonists attenuates vascular lesion formation. The fac
tors that regulate PPAR gamma expression in the vasculature are poorly defi
ned. Here we report that platelet-derived growth factor (PDGF) upregulates
PPAR gamma by the phosphatidylinositol 3-kinase (PI3-kinase)/ Akt signaling
pathway. Using Northern-blotting and Western-blotting analyses, we observe
d that the levels of PPAR gamma mRNA and protein were increased by 2- to 3.
5-fold in human aortic smooth muscle cells (HASMCs) treated with PDGF (20 n
g/mL). This was abolished by preincubation of HASMCs with a PI3-kinase inhi
bitor (LY294002, 50 mu mol/L), and partially inhibited by a MEK1 inhibitor
(U0126, 10 mu mol/L), but not affected by a p38 kinase inhibitor (SB202190,
10 mu mol/L). In addition, overexpression of the dominant-negative p85 sub
unit of PI3-kinase or Akt proteins blocked the PDGF-induced PPAR gamma expr
ession. Taken together, our results suggest that PDGF induces PPAR gamma ex
pression in VSMCs by a PI3-kinase/Akt signaling pathway. The characterizati
on of factors and signaling pathways that modulate PPAR gamma expression in
VSMCs may have important implications for understanding the pathogenesis o
f vascular diseases.